A calcium antagonist, nifedipine, modifies exercise-induced asthma.
about
The cellular and molecular basis of bitter tastant-induced bronchodilationInhibition of histamine release from dispersed human lung and tonsillar mast cells by nicardipine and nifedipineEffects of calcium channel blockade on histamine induced bronchoconstriction in mild asthma.Influence of diltiazem on bronchoconstriction induced by cold air breathing during exerciseDose-response relationship and time-course of the effect of inhaled magnesium sulphate on airflow in normal and asthmatic subjectsNitrendipine therapy in asthmatic subjects.Inhibition of exercise-induced asthma by nifedipine: a dose-response study.DMAP: a connectivity map database to enable identification of novel drug repositioning candidates.Efficacy of calcium channel blockers as maintenance therapy for asthmaEffect of nifedipine on bronchoconstriction induced by inhalation of cold airAsthma in children and adolescents: a comprehensive approach to diagnosis and management.Clinical studies with calcium antagonists in asthma.Promising uses of calcium-channel blocking agents.Verapamil inhibits mediator release from human lung in vitro.Calcium-channel blockers and asthma.Exercise-induced asthma. Diagnostic clues with recommendation for treatment.Calcium channel antagonists in the treatment of asthma.Use of calcium channel blocking agents in the management of childhood asthma.Lack of effect of leukotriene D4 on Ca-uptake in airway smooth muscle.Effects of five different organic calcium antagonists on guinea-pig isolated tracheaNifedipine enhances the bronchodilator effect of salbutamol.Sodium cromoglycate, verapamil and nicardipine antagonism to leukotriene D4 bronchoconstriction.The effect of nifedipine on exercise-induced asthma.Synergism of ochratoxin B and calcium-channel antagonist verapamil caused mitochondrial dysfunction.Comparison of nifedipine with a new calcium channel blocker, flordipine, in exercise-induced asthma.Dry air-induced bronchoconstriction--a role for voltage-sensitive calcium channels?Safety and efficacy of nifedipine 20 mg tablets in hypertension using electronic data collection in general practice.Role of calcium channel blocking agents in the treatment of allergic asthma.Effect of verapamil inhalation on bronchial asthma.The effect of oral diltiazem on airway reactivity to methacholine and exercise in subjects with mild intermittent asthma.In vivo bronchodilator activity of nifedipine in the guinea pig.Use of inhaled calcium channel blocking agents in the treatment of asthma.Calcium channel blocking agents in bronchial hyperreactivity.
P2860
Q27318226-46C2FEFB-540E-4A2E-AAB0-DAB973F879E9Q28336159-C6B77A2C-CAE6-4AF6-BB52-66E253D2C80EQ33603591-34C430EC-05AA-4026-A6DC-191C18D25CB3Q33603595-DDEA7E74-8A33-48CF-AF5F-2AC695BE8977Q34347682-24EFE408-CC81-41D0-AE68-D16B802C2AA6Q34357304-87A8FD5B-1B15-4FFD-A171-2B5ADBCA6469Q34417031-AD1CE96C-C76F-4B80-ACA2-883FC79EEE52Q35794274-F594DE62-60FA-4557-A200-9F2452174D9BQ35803726-EF1AFE37-70EE-4627-85A2-4BEA29C0EE88Q36129555-FA82275E-F6A2-4BEC-AA54-4E2EFFAAD961Q37970318-21672880-A02B-4F10-8825-9FAE574E7687Q39831623-2530C8E4-BAB9-46F3-8B56-F0D955BDDBF6Q40180935-0FB735BD-7548-486A-B844-63040BA430D3Q41120091-11B9683B-9BC2-4217-A968-4C9BDDD03927Q41120190-CEFE5D45-68A9-4B3C-B17C-9A23DDF81383Q41383359-45DA6012-4A06-4D00-99EF-C102510C5387Q41436129-D521B08C-DF5C-4EAA-83DC-C77E785ECFB6Q41573684-7F327588-8C17-4D80-BE64-29ADDCD767FAQ41740685-B9363DA0-F413-47E6-8F34-498880D87C68Q41743514-89ECAAC2-E704-4E59-95E9-CB30BAB8EFDEQ41893980-47C72EC3-883D-466C-B708-7D9A00BBDBA5Q41894370-F49C5BC6-B885-47F4-9F16-BF5E6A2A29B4Q43829254-1E702B01-D5C9-4939-AABE-0BA2B5BAC115Q45285609-2CABBF8C-2D54-4133-8833-18D3D790A371Q46296638-AB386D9A-9DF6-4C49-8480-A82A0EA1DE27Q46410209-678304EC-FCE6-454C-8FF6-A4919725379AQ50954448-031EFC5C-AC25-4E9D-9401-DF7BB5CF0A59Q53917571-E3022F54-9AA9-4006-BACA-A25FE25C69AEQ54333804-8BC954CB-D84D-4588-B66C-646BD0C06B82Q54398089-2AF32EF7-A3DC-4278-BA24-09841034DB9DQ54403884-EFA97FD1-21CD-475B-A83F-2780A585128AQ54483284-2334D4F4-8E69-469C-85B5-0A627F24A310Q54483884-782C9E7E-289A-4538-871F-4E006BE7D3FE
P2860
A calcium antagonist, nifedipine, modifies exercise-induced asthma.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh
1981年學術文章
@zh-hant
name
A calcium antagonist, nifedipine, modifies exercise-induced asthma.
@ast
A calcium antagonist, nifedipine, modifies exercise-induced asthma.
@en
type
label
A calcium antagonist, nifedipine, modifies exercise-induced asthma.
@ast
A calcium antagonist, nifedipine, modifies exercise-induced asthma.
@en
prefLabel
A calcium antagonist, nifedipine, modifies exercise-induced asthma.
@ast
A calcium antagonist, nifedipine, modifies exercise-induced asthma.
@en
P2093
P2860
P356
P1433
P1476
A calcium antagonist, nifedipine, modifies exercise-induced asthma.
@en
P2093
P2860
P304
P356
10.1136/THX.36.10.726
P407
P577
1981-10-01T00:00:00Z